Requirement applications for deliberate release of gmo’s application for COVID-19 clinical trials COVID-19 is temporarily suspended

On July 17 2020 the European Commission published a regulation that a day later, on 2020, July 18 took effect .

07/21/2020 - 14:16

From 13 March 2020, submission of research dossiers for gene therapy and medicinal products containing GMOs takes place directly to the relevant authority

From 13 March 2020, research dossiers in the field of gene therapy and medicinal products containing GMOs must be submitted directly to the relevant authority (CCMO Central Committee on Research invol
03/16/2020 - 20:20